Calumet Specialty Products Stock Current Valuation
| CLMT Stock | USD 21.38 0.45 2.06% |
Valuation analysis of Calumet Specialty helps investors to measure Calumet Specialty's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value Over EBITDA is likely to drop to 6.02 in 2024. Enterprise Value Multiple is likely to drop to 6.02 in 2024. Fundamental drivers impacting Calumet Specialty's valuation include:
Price Book 19.3228 | Enterprise Value 3.9 B | Enterprise Value Ebitda 689.5232 | Price Sales 0.4356 | Forward PE 11.3507 |
Undervalued
Today
Please note that Calumet Specialty's price fluctuation is not too volatile at this time. Calculation of the real value of Calumet Specialty is based on 3 months time horizon. Increasing Calumet Specialty's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Calumet Specialty's intrinsic value may or may not be the same as its current market price of 21.38, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 21.38 | Real 22.8 | Target 25.0 | Hype 21.43 |
The intrinsic value of Calumet Specialty's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Calumet Specialty's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Calumet Specialty Products helps investors to forecast how Calumet stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Calumet Specialty more accurately as focusing exclusively on Calumet Specialty's fundamentals will not take into account other important factors: Calumet Specialty Products Company Current Valuation Analysis
Calumet Specialty's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Calumet Specialty Current Valuation | 3.86 B |
Most of Calumet Specialty's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Calumet Specialty Products is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Calumet Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Calumet Specialty is extremely important. It helps to project a fair market value of Calumet Stock properly, considering its historical fundamentals such as Current Valuation. Since Calumet Specialty's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Calumet Specialty's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Calumet Specialty's interrelated accounts and indicators.
Click cells to compare fundamentals
Calumet Current Valuation Historical Pattern
Today, most investors in Calumet Specialty Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Calumet Specialty's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Calumet Specialty current valuation as a starting point in their analysis.
Calumet Specialty Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Calumet Specialty Products has a Current Valuation of 3.86 B. This is 90.1% lower than that of the Oil, Gas & Consumable Fuels sector and 58.0% lower than that of the Energy industry. The current valuation for all United States stocks is 76.77% higher than that of the company.
Calumet Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Calumet Specialty's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Calumet Specialty could also be used in its relative valuation, which is a method of valuing Calumet Specialty by comparing valuation metrics of similar companies.Calumet Specialty is currently under evaluation in current valuation category among its peers.
Calumet Specialty Current Valuation Drivers
We derive many important indicators used in calculating different scores of Calumet Specialty from analyzing Calumet Specialty's financial statements. These drivers represent accounts that assess Calumet Specialty's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Calumet Specialty's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 285.5M | 245.3M | 1.0B | 1.3B | 1.4B | 1.1B | |
| Enterprise Value | 1.6B | 1.5B | 2.6B | 3.0B | 3.6B | 1.9B |
Calumet Specialty ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Calumet Specialty's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Calumet Specialty's managers, analysts, and investors.Environmental | Governance | Social |
Calumet Fundamentals
| Return On Equity | -11.72 | ||||
| Return On Asset | 0.0167 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 3.86 B | ||||
| Shares Outstanding | 85.9 M | ||||
| Shares Owned By Insiders | 21.24 % | ||||
| Shares Owned By Institutions | 37.43 % | ||||
| Number Of Shares Shorted | 5.37 M | ||||
| Price To Earning | 286.67 X | ||||
| Price To Book | 19.32 X | ||||
| Price To Sales | 0.44 X | ||||
| Revenue | 4.18 B | ||||
| Gross Profit | 370.2 M | ||||
| EBITDA | 418.2 M | ||||
| Net Income | 47.1 M | ||||
| Cash And Equivalents | 50.5 M | ||||
| Cash Per Share | 0.64 X | ||||
| Total Debt | 2.19 B | ||||
| Current Ratio | 0.60 X | ||||
| Book Value Per Share | (7.83) X | ||||
| Cash Flow From Operations | (14.9 M) | ||||
| Short Ratio | 7.59 X | ||||
| Earnings Per Share | (2.82) X | ||||
| Price To Earnings To Growth | 2.71 X | ||||
| Target Price | 24.6 | ||||
| Number Of Employees | 1.58 K | ||||
| Beta | 1.91 | ||||
| Market Capitalization | 1.84 B | ||||
| Total Asset | 2.75 B | ||||
| Retained Earnings | (421.9 M) | ||||
| Working Capital | (318 M) | ||||
| Current Asset | 609 M | ||||
| Current Liabilities | 626.6 M | ||||
| Net Asset | 2.75 B |
About Calumet Specialty Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Calumet Specialty Products's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Calumet Specialty using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Calumet Specialty Products based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Calumet Stock Analysis
When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.